SCHEMBL23837371

SCHEMBL23837371

CC(=O)CCCC(=O)N[C@H]1Cc2cccc(C(=O)OCI)c2OB1O

nearest known ligand 0.47

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
▸ MAPT P10636 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23837520 0.94 PARP1 (0.30) —
SCHEMBL17337392 0.91 TSHR (0.35) MAPT
SCHEMBL17337390 0.91 TSHR (0.35) MAPT
SCHEMBL17347856 0.90 LMNA (0.37) MAPT
SCHEMBL23129898 0.90 LMNA (0.37) MAPT
SCHEMBL23129717 0.90 MAPT (0.30) MAPT
SCHEMBL17347699 0.90 MAPT (0.31) MAPT
SCHEMBL23130274 0.90 MAPT (0.31) MAPT
SCHEMBL23130031 0.89 — —
SCHEMBL23130264 0.89 TSHR (0.40) MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3882252-A1 BETA-LACTAMASE INHIBITORS Venatorx Pharmaceuticals, Inc. (US) 2021-09-22 — — EP disclosed
Send feedback